Comprehensive Assessment of the STIMs and Orais Expression in Polycystic Ovary Syndrome
- 1Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China
- 2Key laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China
- 3Shandong Key Laboratory of Reproductive Medicine, Jinan, China
- 4Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China
- 5National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, China
- 6Department of Reproductive Medicine, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, China
- 7Xiamen Key Laboratory of Reproduction and Genetics, Xiamen, China
- 8Shandong Provincial Maternal and Child Health Care Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
- 9Guangdong Provincial People’s Hospital, Guangzhou, China
A Corrigendum on:
Comprehensive assessment of the STIMs and orais expression in polycystic ovary syndrome
By Song T, Li P, Wang Q, Hao B, Wang Y, Bian Y and Shi Y (2022). Front. Endocrinol. 13:874987. doi: 10.3389/fendo.2022.874987
In the published article, an author name was incorrectly written as Qiuming Wang. The correct spelling is Qiumin Wang.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: polycystic ovary syndrome, store-operated Ca2+ entry, STIM1, Orai1, STIM2
Citation: Song T, Li P, Wang Q, Hao B, Wang Y, Bian Y and Shi Y (2022) Corrigendum: Comprehensive assessment of the STIMs and Orais expression in polycystic ovary syndrome. Front. Endocrinol. 13:1005894. doi: 10.3389/fendo.2022.1005894
Received: 28 July 2022; Accepted: 29 July 2022;
Published: 16 August 2022.
Approved by:
Frontiers Editorial Office, Media SA, SwitzerlandCopyright © 2022 Song, Li, Wang, Hao, Wang, Bian and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yuhua Shi, c2hpeXVodWEyMDAzQDEyNi5jb20=
†These authors share first authorship